Stock listing
NASDAQ:HALO Halozyme Therapeutics, Inc. Stock
Home listing (NASDAQ) of Halozyme Therapeutics, Inc.
Follow Halozyme Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:HALO
$124.83 USD +0.46 (+0.4%)
Close on Oct 21, 2026
- Day range
- $122.71 – $125.43 USDOct 21, 2026
- Volume
- 1.72M sharesOct 21, 2026
- Market cap
- $14.17B USDAt the close on Oct 21, 2026 · price × 113.5M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HALO · Home | $124.83 USD | +0.46 (+0.4%) | 1,715,745 | $124.37 | $125.43 | $122.71 | $124.37 | Close on Oct 21, 2026 |
| Frankfurt:RV7 | €111.30 EUR | +0.85 (+0.8%) | 176 | €110.50 | €111.30 | €110.30 | €110.45 | Close on Oct 21, 2026 |
| LSE:0J2O | $123.98 USD | -0.37 (-0.3%) | 396 | $123.01 | $127.33 | $122.51 | $124.35 | Close on Oct 21, 2026 |
Daily closes
Last 3 months, Jul 21, 2026 – Oct 21, 2026 · NASDAQ:HALO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $124.83 | +0.46 | +0.4% | $124.37 | $125.43 | $122.71 | 1,715,745 | |
| $124.37 | +1.87 | +1.5% | $123.72 | $125.10 | $123.00 | 2,148,955 | |
| $122.50 | +0.66 | +0.5% | $121.72 | $123.60 | $121.69 | 1,893,435 | |
| $121.84 | +0.33 | +0.3% | $122.24 | $122.45 | $120.19 | 2,082,169 | |
| $121.51 | +4.69 | +4.0% | $118.08 | $122.33 | $117.38 | 2,469,499 | |
| $116.82 | +7.20 | +6.6% | $109.90 | $119.21 | $109.42 | 3,769,000 | |
| $109.62 | -1.46 | -1.3% | $111.92 | $111.92 | $108.80 | 1,772,622 | |
| $111.08 | +0.66 | +0.6% | $110.19 | $112.43 | $109.96 | 1,660,300 | |
| $110.42 | +0.58 | +0.5% | $109.70 | $112.65 | $109.70 | 1,845,300 | |
| $109.84 | -0.95 | -0.9% | $109.41 | $110.64 | $107.41 | 2,490,300 | |
| $110.79 | +1.07 | +1.0% | $111.62 | $114.00 | $110.16 | 2,179,300 | |
| $109.72 | +1.41 | +1.3% | $108.87 | $111.25 | $107.43 | 1,774,300 | |
| $108.31 | -1.55 | -1.4% | $109.62 | $109.87 | $107.68 | 1,855,900 | |
| $109.86 | +2.92 | +2.7% | $106.96 | $109.99 | $106.65 | 2,599,800 | |
| $106.94 | -3.46 | -3.1% | $109.93 | $110.50 | $106.84 | 2,329,000 | |
| $110.40 | -1.16 | -1.0% | $111.54 | $112.45 | $110.35 | 3,521,100 | |
| $111.56 | -1.33 | -1.2% | $112.89 | $114.52 | $111.03 | 2,872,900 | |
| $112.89 | -1.01 | -0.9% | $113.34 | $113.94 | $112.10 | 2,236,700 | |
| $113.90 | -1.32 | -1.1% | $115.36 | $115.63 | $113.43 | 1,958,300 | |
| $115.22 | +2.78 | +2.5% | $112.13 | $116.09 | $111.07 | 3,171,600 | |
| $112.44 | -2.69 | -2.3% | $116.85 | $116.85 | $112.18 | 2,702,800 | |
| $115.13 | +3.68 | +3.3% | $111.50 | $115.18 | $110.95 | 4,150,400 | |
| $111.45 | -1.00 | -0.9% | $112.80 | $113.47 | $111.05 | 2,876,800 | |
| $112.45 | +2.77 | +2.5% | $109.72 | $112.66 | $109.38 | 10,183,400 | |
| $109.68 | +1.24 | +1.1% | $107.08 | $110.88 | $106.82 | 1,983,600 | |
| $108.44 | +2.19 | +2.1% | $106.66 | $109.63 | $105.50 | 1,709,900 | |
| $106.25 | -1.69 | -1.6% | $108.14 | $108.14 | $106.14 | 1,055,600 | |
| $107.94 | +0.74 | +0.7% | $108.00 | $108.61 | $106.65 | 912,500 | |
| $107.20 | +0.20 | +0.2% | $107.96 | $108.23 | $106.34 | 861,500 | |
| $107.00 | -0.39 | -0.4% | $106.93 | $107.95 | $106.36 | 1,464,400 | |
| $107.39 | -0.92 | -0.8% | $107.67 | $108.79 | $106.62 | 1,746,300 | |
| $108.31 | -1.88 | -1.7% | $109.00 | $109.96 | $106.07 | 1,625,600 | |
| $110.19 | -0.57 | -0.5% | $109.91 | $111.15 | $109.00 | 1,010,600 | |
| $110.76 | +1.10 | +1.0% | $109.84 | $111.15 | $108.74 | 1,889,600 | |
| $109.66 | +1.94 | +1.8% | $105.84 | $109.76 | $105.48 | 1,619,200 | |
| $107.72 | +1.23 | +1.2% | $107.45 | $108.53 | $106.87 | 1,058,600 | |
| $106.49 | +1.14 | +1.1% | $104.48 | $106.94 | $103.47 | 1,280,000 | |
| $105.35 | -1.57 | -1.5% | $106.45 | $106.81 | $104.70 | 1,681,800 | |
| $106.92 | -0.14 | -0.1% | $106.87 | $107.55 | $106.05 | 1,364,600 | |
| $107.06 | -2.26 | -2.1% | $109.32 | $109.66 | $107.00 | 1,705,800 | |
| $109.32 | +0.68 | +0.6% | $109.33 | $109.55 | $107.55 | 1,598,158 | |
| $108.64 | +0.47 | +0.4% | $108.00 | $109.10 | $106.87 | 2,091,282 | |
| $108.17 | +2.05 | +1.9% | $106.20 | $108.49 | $105.91 | 1,150,300 | |
| $106.12 | -1.50 | -1.4% | $106.41 | $107.44 | $105.20 | 1,577,500 | |
| $107.62 | +2.73 | +2.6% | $106.39 | $107.96 | $105.50 | 2,539,100 | |
| $104.89 | +1.89 | +1.8% | $102.95 | $105.11 | $102.39 | 1,955,300 | |
| $103.00 | +4.34 | +4.4% | $98.86 | $104.09 | $98.58 | 2,199,600 | |
| $98.66 | -2.01 | -2.0% | $100.35 | $100.83 | $98.13 | 1,658,900 | |
| $100.67 | -1.12 | -1.1% | $101.95 | $102.40 | $99.41 | 1,982,800 | |
| $101.79 | -0.83 | -0.8% | $102.00 | $102.58 | $100.47 | 3,650,500 | |
| $102.62 | 0.00 | 0.0% | $103.62 | $104.78 | $101.81 | 2,846,000 | |
| $102.62 | -0.50 | -0.5% | $102.67 | $104.77 | $101.11 | 4,935,000 | |
| $103.12 | +17.36 | +20.2% | $90.00 | $103.30 | $90.00 | 7,691,600 | |
| $85.76 | +2.17 | +2.6% | $84.15 | $86.00 | $82.60 | 2,704,000 | |
| $83.59 | +0.36 | +0.4% | $83.89 | $84.40 | $82.98 | 1,262,600 | |
| $83.23 | +0.96 | +1.2% | $82.78 | $83.89 | $81.75 | 1,574,600 | |
| $82.27 | -0.27 | -0.3% | $82.42 | $83.62 | $82.11 | 1,367,700 | |
| $82.54 | -0.76 | -0.9% | $83.19 | $83.27 | $81.50 | 1,564,600 | |
| $83.30 | +0.02 | 0.0% | $81.74 | $83.54 | $81.21 | 2,135,800 | |
| $83.28 | -0.17 | -0.2% | $83.08 | $83.96 | $82.60 | 1,634,200 | |
| $83.45 | +1.97 | +2.4% | $82.70 | $84.44 | $82.36 | 2,623,600 | |
| $81.48 | -0.45 | -0.5% | $82.41 | $83.50 | $81.46 | 1,435,900 | |
| $81.93 | +1.09 | +1.3% | $81.35 | $82.99 | $80.93 | 1,661,100 | |
| $80.84 | +3.02 | +3.9% | $77.43 | $81.19 | $76.82 | 1,751,400 | |
| $77.82 | -0.78 | -1.0% | $79.23 | $79.31 | $77.40 | 1,399,900 | |
| $78.60 | +1.51 | +2.0% | $76.96 | $78.64 | $76.96 | 1,273,000 |
- Ticker
- NASDAQ:HALO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 7, 2026
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
Latest earnings call · Aug 6, 2026
Halozyme Therapeutics (NASDAQ:HALO) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Q2 2026 Earnings Presentation
Earnings · 15 slides
Calls
Replays
Halozyme Therapeutics (NASDAQ:HALO) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptHalozyme Therapeutics (NASDAQ:HALO) Q1 2026 Earnings Call
Mon, May 11, 2026 · 4:30 PM ET
Watch TranscriptHalozyme Therapeutics (NASDAQ:HALO) Q4 2025 Earnings Call
Wed, Jan 28, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
Oct 7, 2026
Closed $110.79 (+1.0%) on Oct 7, 2026
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology
Oct 6, 2026
Closed $110.79 (+1.0%) on Oct 7, 2026
Halozyme Announces Appointment of Jim Daly to its Board of Directors
Sep 30, 2026
Closed $106.94 (-3.1%) on Oct 1, 2026
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
Sep 17, 2026
Closed $112.45 (+2.5%) on Sep 18, 2026
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
Sep 16, 2026
Closed $109.68 (+1.1%) on Sep 17, 2026
Halozyme Appoints Dannielle Appelhans to its Board of Directors
Aug 18, 2026
Closed $107.62 (+2.6%) on Aug 19, 2026
Halozyme reports record second quarter 2026 results, beats estimates and raises full year 2026 financial guidance
Aug 6, 2026
Closed $103.12 (+20.2%) on Aug 7, 2026
Halozyme to Report Second Quarter 2026 Financial and Operating Results
Jul 23, 2026
Closed $80.84 (+3.9%) on Jul 23, 2026
Financings
1.50% convertible senior notes due 2033
Sep 18, 2026
Made bigger: US$1.3B
Use of proceeds: About $162.5 million to fund the cost of capped call transactions
Decks
Q2 2026 Earnings Presentation
Earnings · 15 slides · Aug 6, 2026
Q1 2026 Earnings Presentation
Earnings · 17 slides · May 11, 2026
FY2025 Earnings Presentation
Earnings · 18 slides · Feb 17, 2026
Q4 2025 Earnings Presentation
Earnings · 26 slides · Jan 28, 2026
Halozyme Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 41 in the last 12 months · 219 in all · newest Oct 7, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 6, 2026
- Decks
- 61 decks · latest Aug 6, 2026
Where Halozyme Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HALO · Home listing · This page | NASDAQ | United States | USD |
| gettex:RV7 | gettex | Germany | EUR |
| Tradegate:RV7 | Tradegate | Germany | EUR |
| LS Exchange:A0DLHS | LS Exchange | Germany | EUR |
| BOATS:HALO | BOATS | United States | USD |
| Frankfurt:RV7 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A0DLHS | Lang & Schwarz | Germany | EUR |
| BMV:HALO | BMV | Mexico | MXN |
| LSE:0J2O | LSE | United Kingdom | USD |
| Milan:1HALO | Milan | Italy | EUR |
| BIVA:HALO | BIVA | Mexico | MXN |
| BX Swiss:RV7 | BX Swiss | Switzerland | CHF |
| Dusseldorf:RV7 | Dusseldorf | Germany | EUR |
| Hamburg:RV7 | Hamburg | Germany | EUR |
| Munich:RV7 | Munich | Germany | EUR |
| Stuttgart:RV7 | Stuttgart | Germany | EUR |
| Hanover:RV7 | Hanover | Germany | EUR |
| Xetra:RV7 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Halozyme Therapeutics, Inc.